Preoperative Portal Venous and Hepatic Arterial Embolization of Tumor

ABSTRACT

Although the goal of embolization is usually to create therapeutic ischemia or hemostasis without surgery, the rationale for preoperative embolotherapy is different in several respects. First, the aim is to prepare patients for definitive surgical resection rather than cure or palliation, and, thus, the goals and expectations are limited and defined by close communication between the interventionalist and the surgeon. Second, when considering segmental resection, the normal liver should be protected from procedural damage. Third, the search for extrahepatic disease is crucial for these patients because resection is typically abandoned in favor of alternative therapies for patients with systemic disease. Finally, intraoperative ultrasound should always be considered to survey the future liver remnant for unsuspected small tumors and allow ablation of these lesions to maximize the success of partial hepatectomy. This article describes preoperative hepatic arterial and portal venous embolization in patients with or without cirrhosis complicated by tumors judged eligible for surgical resection or orthotopic liver transplantation (OLT). Each type of embolization will be reviewed in terms of indications and contraindications, technique, and complications. Finally, the outcomes will be evaluated in terms of morbidity, mortality, and tumor recurrence rates.

KEYWORDS

Liver surgery - liver cancer - liver metastases - transcatheter arterial chemoembolization - portal vein embolization

REFERENCES

• 1 Colombo M, de Franchis R, Del Ninno E et al.. Hepatocellular carcinoma in Italian patients with cirrhosis.  N Engl J Med. 1991;  325(10) 675-680
• 2 Tsukuma H, Hiyama T, Tanaka S et al.. Risk factors for hepatocellular carcinoma among patients with chronic liver disease.  N Engl J Med. 1993;  328(25) 1797-1801
• 3 Yoo H Y, Patt C H, Geschwind J F et al.. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time.  J Clin Oncol. 2003;  21(23) 4329-4335 , (Epub 2003 Oct 27)
• 4 Mazzaferro V, Regalia E, Doci R et al.. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.  N Engl J Med. 1996;  334 693-699
• 5 Llovet J M, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.  Hepatology. 1999;  30 1434-1440
• 6 Bismuth H, Majno P E, Adam R. Liver transplantation for hepatocellular carcinoma.  Semin Liver Dis. 1999;  19 311-322
• 7 Yao F Y, Xiao L, Bass N M et al.. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging.  Am J Transplant. 2007;  7(11) 2587-2596
• 8 Roayaie S, Frisher J S, Emre S H et al.. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters.  Ann Surg. 2002;  235 533-539
• 9 Harnois D M, Steers J, Andrews J C et al.. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma.  Liver Transpl Surg. 1999;  5 192-199
• 10 Graziadei I W, Sandmueller H, Waldenberger P et al.. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.  Liver Transpl. 2003;  9 557-563
• 11 Patel S, Tuite C M, Mondschein J I et al.. Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients with previous biliary intervention.  J Vasc Interv Radiol. 2006;  17(12) 1931-1934
• 12 Zhu A X, Blaszkowsky L S, Ryan D P et al.. Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma.  J Clin Oncol. 2006;  24(12) 1898-1903
• 13 Pang R W, Poon R T. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.  Oncology. 2007;  72(Suppl 1) 30-44
• 14 Jaeger H J, Mehring U M, Castaneda F et al.. Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma.  Cardiovasc Intervent Radiol. 1996;  19 388-396
• 15 Geschwind J F, Ramsey D E, van der Wal B C et al.. Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency.  Cardiovasc Intervent Radiol. 2003;  26 111-117
• 16 Zhang Z, Liu Q, He J et al.. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.  Cancer. 2000;  89 2606-2612
• 17 Paye F, Jagot P, Vilgrain V et al.. Preoperative chemoembolization of hepatocellular carcinoma: a comparative study.  Arch Surg. 1998;  133 767-772
• 18 Muto Y, Moriwaki H, Ninomiya M et al.. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma.  N Engl J Med. 1996;  334 1561-1567
• 19 Decaens T, Roudot-Thoraval F, Bresson-Hadni S et al.. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.  Liver Transpl. 2005;  11 767-775
• 20 Pérez Saborido B, Meneu J C, Moreno E et al.. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?.  Am J Surg. 2005;  190(3) 383-387
• 21 Ravaioli M, Grazi G L, Ercolani G et al.. Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence alter liver transplantation.  Transplantation. 2004;  78 1780-1786
• 22 Adachi E, Matsumata T, Nishizaki T et al.. Effects of preoperative trans-catheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis.  Cancer. 1993;  72 3593-3598
• 23 Xiong Z P, Yang S R, Liang Z Y et al.. Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.  Hepatobiliary Pancreat Dis Int. 2004;  3 386-390
• 24 Kobayashi N, Ishii M, Ueno Y et al.. Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization.  Liver. 1999;  19 25-31
• 25 Otto G, Herber S, Heise M et al.. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.  Liver Transpl. 2006;  12 1260-1267
• 26 Kubota K, Makuuchi M, Kusaka K et al.. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors.  Hepatology. 1997;  26 1176-1181
• 27 de Baere T, Roche A, Elias D et al.. Preoperative portal vein embolization for extension of hepatectomy indications.  Hepatology. 1996;  24 1386-1391
• 28 Madoff D C, Abdalla E K, Vauthey J N. Portal vein embolization in preparation for major liver resection: Evolution of a new standard of care.  J Vasc Interv Radiol. 2005;  16 779-790
• 29 Azoulay D, Castaing D, Krissat J et al.. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver.  Ann Surg. 2000;  232 665-672
• 30 Vauthey J N, Chaoui A, Do K A et al.. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations.  Surgery. 2000;  127 512-519
• 31 Farges O, Malassagne B, Flejou J F et al.. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal.  Ann Surg. 1999;  229 210-215
• 32 de Baere T, Denys A, Madoff D C. Preoperative portal vein embolization: indications and technical considerations.  Tech Vasc Interv Radiol. 2007;  10(1) 67-78
• 33 Farges O, Belghiti J, Kianmanesh R et al.. Portal vein embolization before right hepatectomy: prospective clinical trial.  Ann Surg. 2003;  237 208-217
• 34 de Baere T, Roche A, Vavasseur D et al.. Portal vein embolization: utility for inducing left lobe hypertrophy before surgery.  Radiology. 1993;  188 73-77
• 35 Imamura H, Shimada R, Kubota M et al.. Preoperative portal vein embolization: An audit of 84 patients.  Hepatology. 1999;  29 1099-1105
• 36 Denys A. Portal vein embolisation. 2007 Annual Meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); Athens, Greece, September 8–12. 
• 37 Shimamura T, Nakajima Y, Une Y et al.. Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study.  Surgery. 1997;  121 135-141
• 38 Nagino M, Nimura Y, Kamiya J et al.. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma.  Surgery. 1995;  117 677-681
• 39 Nagino M, Nimura Y, Kamiya J et al.. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization.  Hepatology. 1995;  21 434-439
• 40 Kaneko T, Nakao A, Takagi H. Experimental studies of new embolizing material for portal vein embolization.  Hepatogastroenterology. 2000;  47 790-794
• 41 Nagino M, Nimura Y, Kamiya J et al.. Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach.  Radiology. 1996;  200 559-563
• 42 Ringe K I, Weidemann J, Rosenthal H et al.. Transhepatic preoperative portal vein embolization using the Amplatzer Vascular Plug: report of four cases.  Cardiovasc Intervent Radiol. 2007;  30(6) 1245-1247
• 43 Di Stefano D R, de Baere T, Denys A et al.. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients.  Radiology. 2005;  234 625-630
• 44 Kodama Y, Shimizu T, Endo H et al.. Complications of percutaneous transhepatic portal vein embolization.  J Vasc Interv Radiol. 2002;  13 1233-1237
• 45 Shoup M, Gonen M, D'Angelica M et al.. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection.  J Gastrointest Surg. 2003;  7 325-330
• 46 Wakabayashi H, Yachida S, Maeba T et al.. Indications for portal vein embolization combined with major hepatic resection for advanced-stage hepatocellular carcinoma: a preliminary clinical study.  Dig Surg. 2000;  17 587-594
• 47 Tanaka H, Hirohashi K, Kubo S et al.. Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function.  Br J Surg. 2000;  87 879-882
• 48 Azoulay D, Castaing D, Smail A et al.. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization.  Ann Surg. 2000;  231 480-486
• 49 Ogata S, Belghiti J, Farges O et al.. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma.  Br J Surg. 2006;  93 1091-1098
• 50 Aoki T, Imamura H, Hasegawa K et al.. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma.  Arch Surg. 2004;  139 766-774
• 51 Elias D, De Baere T, Roche A et al.. During liver regeneration following right portal embolization, the growth rate of liver metastases is more rapid than that of the liver parenchyma.  Br J Surg. 1999;  86 784-788